Metastatic castration-resistant prostate carcinoma

Clinical trials for Metastatic castration-resistant prostate carcinoma explained in plain language.

Never miss a new study

Get alerted when new Metastatic castration-resistant prostate carcinoma trials appear

Sign up with your email to follow new studies for Metastatic castration-resistant prostate carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 7 Not yet recruiting 1 Not yet finished but already full! 4

Could a stronger first dose of targeted radiation beat back advanced prostate cancer?

Disease control Not yet recruiting

This phase 1 trial tests whether giving a higher first dose of the radioactive drug Lu-177-PSMA-617 can improve treatment for men with metastatic castration-resistant prostate cancer. The drug targets a protein on prostate cancer cells and delivers radiation to kill them. Researc…

Matched conditions: METASTATIC CASTRATION-RESISTANT PROSTATE CARCINOMA

Phase 1 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control

Last updated Jul 08, 2026 00:00 UTC

Metastatic castration-resistant prostate carcinoma

Get alerted when new Metastatic castration-resistant prostate carcinoma trials appear

Could a stronger first dose of targeted radiation beat back advanced prostate cancer?